By Editor , 1 October 2026
Modaxo Launches Novvan, Routeward After Conduent Unit Buy

Toronto – October 01, 2026 -- Modaxo Inc. has completed its largest acquisition to date, absorbing over 2,000 employees across 15 countries from Conduent Incorporated's Transit Fare Management and Fleet Management Solutions businesses.

Modaxo splits acquired Conduent units into two new business brands

The two divisions have been relaunched as standalone Modaxo units: Novvan, a fare collection technology provider for transit agencies, and Routeward, a fleet management platform focused on transit reliability and ridership growth.

By Editor , 1 October 2026
Caylent Named Major Player in IDC Cloud Services Report

Irvine, Calif. – October 01, 2026 -- Caylent has been positioned as a Major Player in the IDC MarketScape: Worldwide Cloud Professional Services 2026 Vendor Assessment, a ranking that evaluated 27 vendors across the global cloud professional services market.

By Editor , 1 October 2026
Equinix Sets Oct. 28 Call to Report Q3 2026 Results

Redwood City, Calif. – October 01, 2026 -- Equinix, Inc. (Nasdaq: EQIX) will report third-quarter 2026 results for the period ended September 30, 2026, during a conference call scheduled for Wednesday, October 28, 2026, at 5:30 p.m. ET.

Equinix confirms October 28 call time and dial-in details

The call will take place at 2:30 p.m. PT. Participants can dial 1-517-308-9482 domestically and internationally using passcode EQIX, with a simultaneous live webcast available on the company's Investor Relations site.

By Editor , 1 October 2026
Corero Named Star for Second Year in DDoS Market Report

London – – October 01, 2026 -- Corero Network Security (AIM: CNS; OTCQX: DDOSF) has strengthened its position as a Star for the second consecutive year in the "DDoS Protection and Mitigation Market – Global Forecast to 2031" report published by MarketsandMarkets.

By Editor , 1 October 2026
AppZen's ZenLM Plus Beats Frontier Models on Expense Audits

San Jose, Calif. – October 01, 2026 -- AppZen has launched ZenLM Plus, a family of finance-specialized large language models that outperformed seven frontier AI models on expense audit accuracy while cutting inference costs, the company announced.

By Editor , 1 October 2026
Lutris Pharma's LUT014 Gel Hits 71.8% Success Rate in Phase 2 Rash Trial

Tel Aviv, Israel – October 01, 2026 -- Lutris Pharma reported that its topical B-Raf inhibitor LUT014 achieved Treatment Success in 71.8% of patients with EGFR inhibitor-induced acneiform rash, compared with 38.5% on placebo (p=0.003), in updated Phase 2 data presented at the 35th EADV Congress in Vienna.